中图分类号：R587.1文献标识码：A

    DOI：10.3969/j.issn.1006-1959.2025.12.029 文章编号：1006-1959(2025)12-0136-04

    Analysis of Clinical Effect and Adverse DrugReactionsof Acarboseand Dapagliflozin intheTreatmentof Type2DiabetesMellitus

    ZHU Jian

    (DepartmentofPharmacy，Yanshan CountyHospitalofTraditionalChinese Medicine，Yanshan3345o，Jiangxi，China)

    Abstract：ObjectieToalyethenicalefectnddversedgreactiosofcarboenddapaglfoinintetreatmentoftyabee mlitus(D.etosigdoerableto63sitdtdtsotitalofdioal ChineseMediefroJauarytoDceber3eredivideditoarboseoup31patints)nddapaglflingrou32patints)hc wertreatediabdalsiellccodosptelodcole bldcoee) fluctuationdeelefccusiGE)filfes)htsted reactionswerecomparedbetweethetogroupsesultsereasnsiificantdiereceinbloodglucosecomplancerateandldglucoe compliance time between the two groups( Pgt;0 0.05).The indexesofFPG，2hPBGand HbAlcinthetwo groups werelower than those before treatment ( Plt; 0.05)，butthere wasnosignificant diffrence inFPG，2hPBGandHbAlc between the two groupsafter treatment( Pgt; 0.05). The values of MAGE and MODD in the dapagliflozin group were lower than those in the acarbose group( P lt;0.05).The bodyweight and waist circumference of the two groupsaftertreaeerelesstantoefotreantndodytandistfereeoftapalifoplesta those of the acarbose group( Plt;0.05 ).The incidence of adverse drug reactions in dapagliflozin group( 3.13% )was lower than that in acarbose group (19.35 % )( P? ......